Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone-soaked Gelfoam in posterolateral lumbar spinal fusion
IRCT20200502047277N6Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of triamcinolone acetonide in lumbar spondylosis (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Postoperative pain at rest and Postoperative pain with movement. Started Oct 2021; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
lumbar spondylosis
Beyond the preview
Go deeper on IRCT20200502047277N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200502047277N6.